Idun And Abbott Extend Partnership Agreement

Idun Pharmaceuticals, Inc. has extended their worldwide research and development agreement with focusing on the discovery and development of products to treat people with cancer.

Under this agreement, Abbott and Idun will continue their collaboration to discover drugs that regulate the activity of specific proteins involved in the cell pathways leading to programmed cell death, or apoptosis.

This strategic initiative combines proprietary technologies from both Abbott and Idun in a major discovery effort to identify small molecule drugs that kill tumour cells by specifically targeting the apoptosis pathway.

Under the original collaboration, which began in 1998, Idun developed primary molecular assays against targets in the core of the apoptosis pathway.

Abbott uses these assays for high-throughput screening of compound libraries and for compound design using Abbott’s proprietary Structure Activity Relationships by Nuclear Magnetic Resonance (SAR by NMR) technology.

Secondary screening is carried out by Idun using its battery of proprietary biological apoptosis assays.

“During the past three years we have made significant progress in the discovery of innovative treatments for cancer through our partnership with Abbott Laboratories,” says Dr. Steven J. Mento, President and CEO, Idun Pharmaceuticals.

“The collaborative program between Abbott and Idun for cancer research has been successful to date and we are pleased to be able to extend our collaboration with Idun,” says Steve Fesik, Ph.D., Divisional Vice President, Cancer Research at Abbott Laboratories.

Idun Pharmaceuticals, Inc. creates innovative human therapeutics with a primary focus on controlling apoptosis, or programmed cell death.

Idun believes that controlling the cell death process will have utility in treating cancer, neurodegenerative diseases, ischemic disorders and cardiovascular disease.

Buy Dragon Pharmaceuticals Overseas

Sustanon 350 - Cheap Price

Administration: Injection
Prime Substance: Testosterone Blend
Made by: Dragon Pharma Labs
Pack: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00

Trenbolone 200

Injectable Anabolic Steroid
Basic Substance: Trenbolone Enanthate
Produced by: Dragon Pharma LLC
Amount: 1 X 10 ml (200 mg/ml)

Winstrol Depot

Injectable Anabolic Steroid
Primary Constituent: Stanozolol
Producer: Dragon Pharma LLC
Pack: 1 X 10 ml (50 mg/ml)

Oxymetholon - Discount Price

Administration: Oral
Principal Constituent: Oxymetholone
Manufacturer: Dragon Pharma Labs
Amount: 30 x 100 tabs (50 mg/tab)
Price: 30 x $51.00


Synthetic Anabolic Steroidal Agent
Primary Chemical Name: Oxandrolone
Branded by: Dragon Pharmaceutical
Amount: 1 X 100 pastilles (50 mg/pill)

Parabolan 100 - Discount Price

Administration: Injection
Prime Substance: Trenbolone Hexahydrobenzylcarbonate
Produced by: Dragon Pharma Labs
Pack: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $45.00

Dianabol 20 - Bulk Price

Administration: Oral
Basic Ingredient: Methandrostenolone
Made by: Dragon Pharma LLC
Pack: 10 x 100 tablets (20 mg/tab)
Price: 10 x $39.00

Masteron 200 - Discount Price

Administration: Injection
Prime Ingredient: Drostanolone Enanthate
Producer: Dragon Pharma
Package: 30 x 10 mL vial (200 mg/mL)
Price: 30 x $49.00

Primobolan 200

Injectable Anabolic Steroid
Basal Substance: Methenolone Enanthate
Made by: Dragon Pharma LLC
Unit: 1 X 10 mL vial (200 mg/mL)

Propionat 100

Injectable Steroid for Muscle Growth
Primary Substance: Testosterone Propionate
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (100 mg/mL)

Trenbolone 50

Injectable Steroid for Muscle Growth
Basal Chemical Name: Trenbolone Suspension
Producer: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (50 mg/mL)


Oral Steroid for Muscle Growth
Active Substance: Oxymetholone
Manufacturer: Dragon Pharmaceuticals
100 pills (50 mg/pill)